01.29.26 -- Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders

Clinical trial capacity in the U.S. is heavily concentrated, and technology is playing a critical role in enabling a shift to expanding site networks and alleviating the burden on sites and patients.

Join us to see how HEOR drives impact across the global healthcare landscape.

As much as eConsent helps staff, participants are also likely to prefer it over traditional paper methods. Unveil the benefits of eConsent and some strategic steps sites can take right now to adopt the process.

By enabling consistent patient–technology engagement, smart hubs provide a sustainable way to support successful, high‑quality clinical trials in an evolving drug‑development landscape.

Discover a new AI Copilot that revolutionizes clinical data analysis and offers seamless deployment with intuitive question-answering, chart generation, and content integration.

Vendor selection isn’t just procedural — it shapes trial outcomes. Even with a solid process, missteps can ripple through timelines, budgets, and team morale. Choose wisely.

Explore how technology-driven, patient-centered innovation is transforming clinical trials to reduce risk, improve efficiency, and deliver smarter development outcomes.

Consider how integrated response technologies and electronic clinical outcomes assessments can improve configurability, study start-up, and flexible mid-study changes.

To navigate the growing number of vendor portals required for clinical trials, sites are seeking a vendor- and sponsor-agnostic solution to enable single sign-on and study organization.

Uncover how this human-centered approach to RTSM prioritizes user experience (UX) and interface design (UI) to reduce complexity, minimize errors, and improve compliance.